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Cells recognize both foreign and host-derived double-stranded RNA (dsRNA) via a signaling
pathway that is usually studied in the context of viral infection. It has become increasingly clear
that the sensing and handling of endogenous dsRNA is also critical for cellular differentiation
and development. The adenosine RNA deaminase, ADAR1, has been implicated as a central
regulator of the dsRNA response, but how regulation of the dsRNA response might mediate cell
fate during injury and whether such signaling is cell intrinsic remain unclear. Here, we show that
the ADAR1-mediated response to dsRNA was dramatically induced in 2 distinct injury models of
gastric metaplasia. Mouse organoid and in vivo genetic models showed that ADAR1 coordinated a
cell-intrinsic, epithelium-autonomous, and interferon signaling–independent dsRNA response. In
addition, dsRNA accumulated within a differentiated epithelial population (chief cells) in mouse
and human stomachs as these cells reprogrammed to a proliferative, reparative (metaplastic) state.
Finally, chief cells required ADAR1 to reenter the cell cycle during metaplasia. Thus, cell-intrinsic
ADAR1 signaling is critical for the induction of metaplasia. Because metaplasia increases cancer
risk, these findings support roles for ADAR1 and the response to dsRNA in oncogenesis.
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Pathogen- and damage-associated molecular patterns (PAMPs, DAMPs) trigger innate immune responses
by engaging pattern recognition receptors (PRRs; ref. 1). An essential innate immune pathway in vertebrates
is the response to double-stranded RNA (dsRNA), a known DAMP/PAMP (2). One arm of the dsRNA
response involves the recognition of foreign (i.e., viral) or host dsRNA by the cytosolic PRRs DDX58 and
MDA5 (interferon induced with helicase C domain 1; IFIH1), leading to downstream activation of type I
interferons (IFNs; e.g., IFN-α, IFN-β) and IFN-stimulated genes (ISGs; refs. 3, 4). Secreted type I IFNs can
also bind cell surface–associated type I IFN receptors (i.e., IFNAR1/2) and can further amplify the innate
immune response in a paracrine and/or autocrine manner (5, 6). Although the host response to dsRNA has
routinely been studied in the context of an antiviral response (7–9), it is becoming clear that host-derived dsRNA can also trigger innate immune signaling (10, 11).
Cells have evolved mechanisms to distinguish self from non-self dsRNA (12), and the failure to suppress
reactivity to self dsRNA can lead to aberrant autoimmunity (13, 14). A key regulator in the intracellular
response to dsRNA is the adenosine RNA deaminase ADAR1, which functions as a rheostat for this pathway via RNA editing–dependent and –independent mechanisms (15). More importantly, ADAR1 is required
during embryonic development, as Adar1–/– mice die by E12.5 and exhibit a significant upregulation of ISGs
and defects in liver development and erythropoiesis (15–17). These mice can be rescued to attain adulthood
when Ifih1 is also deleted (18). ADAR1 is also required for the maintenance of fetal and adult hematopoietic
stem cells (19, 20). Taken together, these findings suggest that the ability to sense and handle dsRNA extends
beyond simply generating an antiviral state but also has critical implications for cell fate and differentiation. A
major unresolved issue is how the cell-intrinsic (i.e., independent of exogenous immune signals, DAMPs, and
PAMPs) regulation of dsRNA determines cell fate during homeostasis or during injury.
1
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In addition to being instrumental to embryogenesis (18) or to the differentiation of adult tissue stem
cells (19), cell identity switches are a critical aspect of the cellular reprogramming that occurs when cells
attempt to regenerate after severe tissue injury (21). Sustained injury in the stomach, for example, leads to
a gradual loss of acid-secreting parietal cells from the gastric corpus (22) and a reorganization of corpus
units into a pattern known as pyloric metaplasia (23) (herein referred to as metaplasia). Metaplasia is
characterized in part by the reprogramming of postmitotic chief cells at the base of the gastric gland into
a proliferating population of spasmolytic polypeptide-expressing metaplastic (SPEM) cells (24), which can
be histologically identified in mice by the coexpression of mucous neck cell markers (e.g., Griffonia simplicifolia, or GSII) and chief cell markers (e.g., gastric intrinsic factor, or GIF) at the gland base (25). Postmitotic
chief cells become SPEM cells via a stepwise cellular reorganization program known as paligenosis, which
first involves a degradation of the secretory machinery, followed by a reexpression of metaplastic markers
prior to cellular proliferation (26). A critical step in paligenosis is the progression of SPEM cells from a
stage where they express metaplastic genes to the final stage, where they reenter the cell cycle to proliferate.
Recent evidence suggests that appropriately regulating the epithelial metaplastic response, in particular the
proliferation of metaplastic cells, has implications for cellular survival and for the development of gastric
cancer (27, 28), the third leading cause of cancer-related deaths worldwide (29). A role for dsRNA signaling in metaplasia or epithelial reprogramming has not been previously reported to our knowledge; however,
ADAR1 has been implicated as a potential oncogene across various gastrointestinal organs (30, 31), including the stomach (32, 33). How ADAR1 increases gastric cancer risk is unclear.
In this study, we establish a potentially novel and previously unexplored role for the ADAR1-mediated
dsRNA response in epithelial injury. We demonstrate that the response to dsRNA was substantially upregulated across 2 established, distinct, in vivo models of epithelial injury and metaplasia in the stomach. Consistent with this, dsRNA accumulated within metaplastic gastric epithelium in mice and in humans. We
also find that the activation of the dsRNA response was independent of IFNAR1 signaling in vivo, indicating that it is not a function of immune signaling but rather cell intrinsic. Finally, we highlight a cell-autonomous, immune cell–independent role for ADAR1 in regulating epithelial reprogramming during injury:
loss of ADAR1 impaired the chief cells’ intrinsic ability to proliferate during paligenosis. Thus, dsRNA
signaling, acting in part through ADAR1, plays a cell-intrinsic role in cellular reprogramming during metaplasia and may help explain how ADAR1 can act as an oncogene in certain situations.

Results
Double-stranded RNA accumulates during gastric metaplasia. To test whether dsRNA signaling is involved in cell
fate decisions during injury, we relied on a previously validated model for acutely and synchronously inducing
gastric metaplasia in mice (high-dose tamoxifen, HD-Tam; refs. 34, 35). We observed a time-dependent accumulation of dsRNA within gastric epithelium undergoing metaplastic changes (Figure 1A). While dsRNA
was absent from gastric epithelium at homeostasis, its accumulation within epithelial cells (Figure 1C) and
chief cells (Figure 1D) peaked within 12 hours of HD-Tam treatment and subsequently returned to baseline
levels by 48 hours (Figure 1, A and B). The peak in epithelial dsRNA preceded the induction of metaplastic
genes, as the dsRNA-positive cells did not show the coexpression of markers for chief and mucous neck cell
genes that are pathognomonic for the transition to metaplasia (Figure 1A) (36). To confirm that the dsRNA
observed within murine metaplastic epithelium was not due to uptake of viral RNA within the stomach, we
intraperitoneally injected gnotobiotic (germ-free) mice with HD-Tam and found that the accumulation of
dsRNA followed similar kinetics as specific pathogen–free mice (Supplemental Figure 1, A and B; supplemental material available online with this article; https://doi.org/10.1172/jci.insight.153511DS1).
We next examined a series of 150 biopsies from human gastric corpus and selected those demonstrating chronic gastritis as determined by the diagnostic pathologist (Table 1). As a control, we also examined
a series of resection specimens from sleeve gastrectomies, all of which showed no histologic evidence of
inflammation. We have previously shown that, in atrophic gastritis, there are regions that exhibit transitions
between normal chief cell and SPEM type metaplastic cell morphology. Such transitions recapitulate the
progression of metaplasia seen in mouse models (26, 37–39). As in control mouse chief cells, dsRNA was
rarely found within normal chief cells in the sleeve gastrectomy specimens (Figure 1E). However, similar
to murine chief cells early after HD-Tam injury, human chief cells that still exhibited a chief cell phenotype in human atrophic gastritis accumulated dsRNA, both within basal chief cells as well as within the
surrounding inflammatory infiltrate (Figure 1, F and G). However, in more established metaplastic cells,
JCI Insight 2022;7(3):e153511 https://doi.org/10.1172/jci.insight.153511
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Figure 1. Double-stranded RNA accumulates within inflamed gastric epithelium. (A) Representative gastric corpus sections from wild-type mice treated with HD-Tam for the indicated times. Isolated dsRNA signal is shown in the top panels and merged images at the bottom. Scale bars, 20 μm. Images
are representative of 3 mice per time point. (B) Quantification of epithelial cells harboring dsRNA. Each data point represents the total dsRNA/E-cadherin double-positive cells within a randomly selected HPF from 3 mice per time point. (C and D) Representative mouse corpus gland bases following 12
hours of HD-Tam demonstrating the accumulation of dsRNA within epithelial cells (C; red) and within chief cells (D; highlighted by GIF in green). Scale
bars, 10 μm. (E–H) dsRNA expression in human gastric epithelium. (F) A gastric corpus biopsy from an H. pylori–positive patient with chronic atrophic
gastritis demonstrates dsRNA (red) within inflamed epithelial cells (outlined in white) and largely absent from metaplastic cells (yellow arrowheads)
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showing GSII positivity (green). (G) A metaplastic corpus gland base from an H. pylori–positive patient with chronic atrophic gastritis demonstrates a
relative paucity of dsRNA within metaplastic epithelium (marked in green; right panel). (H) This metaplastic corpus gland base from an H. pylori–positive
patient with chronic atrophic gastritis shows hybrid features, with dsRNA accumulating in inflamed epithelium but largely excluded from metaplastic
cells. Yellow arrowheads point to metaplastic cells at gland bases that express the mucous neck cell marker, GSII (green), and show a relative paucity of
dsRNA. No dsRNA is seen in uninflamed gastric epithelial cells in an H. pylori–negative, uninflamed gastric biopsy (E). For G and H, isolated dsRNA and
E-cadherin signals are shown in the left panels. Scale bars, 10 μm. HD-Tam, high-dose tamoxifen; GIF, gastric intrinsic factor.

dsRNA was less abundant than in surrounding inflammatory cells (Figure 1G). In basal units with hybrid
morphology, dsRNA abundance showed an inverse correlation with the degree of labeling with the lectin
GSII, a marker of SPEM metaplasia: those cells with abundant GSII (i.e., metaplastic cells) had the least
amount of dsRNA (Figure 1, F and H, and Table 1).
The dsRNA response is conserved across multiple models of gastric metaplasia. As the pattern of dsRNA accumulation in murine chief cells following HD-Tam injury appeared to faithfully model metaplastic transitions in humans, we hypothesized that the response to dsRNA was part of the conserved reprogramming
process that converts normal chief cells into proliferative metaplastic cells (26, 28). To further test this
hypothesis, we used a mouse model for inducing gastric metaplasia in a way that more closely mimics
human metaplasia. Whereas our HD-Tam model described above induces rapid, synchronous, and reversible metaplasia with mild inflammatory cell infiltrate (34), chronic infection with the stomach-adapted
bacterium H. pylori, the biggest risk factor for the development of human gastric adenocarcinoma (40), also
induces gastric metaplasia in mice. Just as in humans, H. pylori infection in mice induces metaplasia in a
more indolent, multifocal, and asynchronous manner than HD-Tam, often with a robust inflammatory
component (35, 41). As expected, both injury models induced metaplastic epithelial changes, despite the
divergent relative role of the immune response (Supplemental Figure 2).
We next used gene expression profiling to take an unbiased approach in determining whether the
response to dsRNA was conserved across these 2 disparate models of gastric metaplasia. Indeed, the most
highly upregulated gene pathways across both models of metaplasia were related to innate immune sensing
and signaling in response to dsRNA (Figure 2A and Table 2), and many of the most substantially induced
transcripts were various components of the dsRNA response. In particular, components of the response
pathway that sense dsRNA and amplify downstream signaling (42) were highly represented (Table 2).
While certain genes were specific to the individual injury model — e.g., Slfn4 specific to chronic H. pylori
infection (43) and Erdr1 specific to HD-Tam — and not previously shown to our knowledge to be involved
in the dsRNA response, a substantial subset of genes related to the dsRNA response was upregulated to a
nearly identical extent across both models (Figure 2B). We validated many of the upregulated genes at the
protein and mRNA levels in both HD-Tam treatment (Figure 2C) and chronic H. pylori infection (Figure
2D). We used commercially available antibodies to localize dsRNA signaling components (e.g., interferon regulatory factor 7, IRF7) within metaplastic glands (Supplemental Figure 3, A–C). In both HD-Tam
treatment and H. pylori infection, the dsRNA response components were largely detected in chief cells, the
same epithelial population in which we had seen an accumulation of dsRNA during the progression to
metaplasia (Figure 1A). Downstream components of the dsRNA response, like IRF7, could be found in
metaplastic (i.e., basal GSII-positive) cells. As might be expected, the accumulation of dsRNA in chief cells
(Figure 1D) preceded the upregulation of the dsRNA response (Supplemental Figure 3C).
Activation of the dsRNA response during metaplasia is independent of type I IFN signaling. Recognition of
dsRNA leads to downstream signaling and the production of type I IFN and ISGs that amplify the cellular
response through autocrine and paracrine mechanisms (5, 6). One aspect of this response is the release of
type I IFN and engagement of the IFNAR1/2 receptor in a paracrine or autocrine manner. This can lead to
propagation of an inflammatory signal via downstream signaling pathways, including STAT1 phosphorylation (6). To test whether gastric metaplasia was dependent on IFNAR1 signaling, we treated Ifnar1–/– mice
with HD-Tam. As expected, Ifnar1–/– mice lacked Ifnar1 mRNA (Figure 3A). Additionally, loss of Ifnar1
was sufficient to abrogate type I IFN signaling as a whole, as gastroids derived from Ifnar1–/– mice, unlike
gastroids from wild-type mice, did not respond to exogenous IFN-β (Figure 3B). Surprisingly, the loss of
type I IFN signaling did not cause any detectable defect in the induction of metaplasia (as determined
histologically), following either HD-Tam treatment or chronic H. pylori infection (Figure 3, C and D).
Moreover, the transcriptional response of Ifnar1–/– mice to HD-Tam was not significantly different from
that of wild-type mice (Figure 3E), and, strikingly, the dsRNA response was activated in the stomachs of
JCI Insight 2022;7(3):e153511 https://doi.org/10.1172/jci.insight.153511

4

RESEARCH ARTICLE

Table 1. Pattern of dsRNA staining in human gastric biopsy samples
Sample number

Pattern of basal dsRNA
staining

dsRNA staining in
metaplastic cells (Y/N)

H. pylori present
(Y/N)

Degree of atrophy

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Strong
Weak
Moderate
Moderate
Moderate
Strong
Strong
Moderate
Moderate
Weak
Strong
Moderate
Strong
Strong
Strong
Moderate
Strong
Moderate
Strong
Moderate

N
N
N
Y (weak)
N
Y (weak)
Y (weak)
N
Y
N
N
N
N
Y (weak)
N
N
N
N
N
Y (weak)

Y
Y
N
N
Y
Y
Y
Y
Y
N
Y
N
Y
Y
Y
N
N
N
Y
Y

None
Mild
Mild
None
None
Mild
Severe
None
None
Moderate
None
Cystic
Mild
None
Mild
Moderate
Mild
None
Moderate
Mild

A total of 20 gastric corpus biopsies from adult patients with chronic gastritis were stained for dsRNA. The pattern of dsRNA staining and presence of
dsRNA in metaplastic cells were determined by a single observer who was blinded to the presence of Helicobacter pylori (H. pylori) and the degree of atrophy.

Ifnar1–/– mice to an almost identical extent as wild-type mice at the mRNA and protein levels (Figure 3, F
and G). Accordingly, dsRNA accumulated within metaplastic gland bases in the stomachs of Ifnar1–/– mice
(Figure 3H). Together, these results indicate that activation of the dsRNA response and the development of
gastric metaplasia do not depend on signaling through the type I IFN receptor.
Assessing the role of ADAR1, a key regulator of the dsRNA response, within gastric epithelium. Given that the
dsRNA response was independent of IFNAR1 signaling, we aimed to identify how the dsRNA response
is regulated during metaplasia. The RNA-editing deaminase ADAR1 has been implicated as being central to regulating intracellular responses against both foreign and endogenous dsRNA (15, 44). ADAR1 is
ubiquitously expressed in a constitutive, nuclear p110 isoform and can be expressed in an IFN-inducible,
activated cytoplasmic p150 isoform (45, 46). Like other components of the dsRNA response, the activated
p150 isoform of ADAR1 was upregulated following both HD-Tam treatment and chronic H. pylori infection
(Figure 4, A and B), and its expression was increased in gastric epithelium undergoing metaplasia (Figure
4C). Moreover, activated ADAR1 expression was significantly upregulated following HD-Tam treatment of
germ-free mice, suggesting that ADAR1 activation was a cell-intrinsic consequence of HD-Tam–induced
metaplasia and not the result of uptake of viral dsRNA (Supplemental Figure 1D).
Along those lines, to demonstrate ADAR1’s role specifically within gastric epithelium, we derived gastroids from Adar1-floxed (Adar1fl/fl) gastric tissue and transduced them ex vivo with a Cre recombinase–expressing adenoviral vector (Ad-Cre). The transduction efficiency of the Ad-Cre, and by extension the efficiency of
Cre-mediated deletion of Adar1, were determined by transducing gastroids derived from Adar1fl/fl mice bearing
a ROSA26LSLTdTomato reporter allele. Loss of Adar1 did not significantly affect gastroid growth (Supplemental
Figure 4). Compared with Ad-Cre–transduced Adar1fl/+ gastroids, Adar1fl/fl gastroids transduced with Ad-Cre
showed a robust activation of the dsRNA response at the mRNA (Figure 4D) and protein levels (Figure 4E).
We next examined our series of chronic gastritis specimens from human gastric corpus biopsies described
above that were immunostained for total ADAR1. Chief cells from an uninflamed gastric corpus were largely
negative for cytoplasmic ADAR1 (Figure 4F). However, in patients with chronic gastritis, cytoplasmic expression of ADAR1, indicative of an increase in the IFN-inducible p150 isoform, could be appreciated in gland base
cells maintaining chief cell morphology (Figure 4G). Cytoplasmic ADAR1 expression tended to be weaker in
JCI Insight 2022;7(3):e153511 https://doi.org/10.1172/jci.insight.153511
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Figure 2. The dsRNA response is upregulated during gastric metaplasia. (A) Gene expression profiling of gastric corpus tissue from wild-type mice
treated with either vehicle (green) or HD-Tam for 48 hours (purple), or infected with H. pylori for 6.5 months (yellow). The hatched area is magnified in
the right panel, with expression changes for the corresponding genes. (B) Genes highlighted in yellow showed higher relative expression following
H. pylori infection, while genes highlighted in purple showed relatively higher expression following HD-Tam treatment. Genes pertaining to the
dsRNA response are in black. Genes in yellow and purple have not been shown to be involved in the dsRNA response. Dotted lines represent 2-fold
cutoffs. (C and D) The dsRNA response is activated at the transcriptional (left panels) and protein (right panels) levels following either HD-Tam treatment (C) or chronic H. pylori infection (D). For left panels, each data point represents gastric corpus tissue from an individual mouse. Fold expression
changes were determined by quantitative reverse transcription PCR (qRT-PCR) and are relative to vehicle-treated (C) or mock-infected mice (D). The
dotted line represents the average expression in vehicle-treated or mock-infected mice. For C, pooled data from 3 consecutive, independent experiments are shown. For C, “V” corresponds to vehicle treatment. For D, each data point represents an individual mouse infected with H. pylori for 3
months (unfilled circles), 6.5 months (half-filled circles), or 11 months (filled circles). Each lane of the Western blots represents gastric corpus tissue
of a mouse from a representative experiment under each experimental treatment condition. For left panels, P values were determined using 2-tailed
Student’s t test, where *, P < 0.05; **, P < 0.01; ***, P < 0.001. HD-Tam, high-dose tamoxifen; Hp, Helicobacter pylori.
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Table 2. Cellular/molecular pathways upregulated during acute and chronic gastric metaplasia
Term name

Defense response to virus
Innate immune response
Response to cytokine
Double-stranded RNA binding
Antiviral mechanism by interferon-stimulated genes
2′-5′ oligoadenylate synthetase activity
Regulation of innate immune response
ISG15 antiviral mechanism
Interferon signaling
Response to type I interferon
Type I interferon signaling pathway

Term ID

GO:0051607
GO:0045087
GO:0034097
GO:0003725
REAC:R-MMU-1169410
GO:0001730
GO:0045088
REAC:R-MMU-1169408
REAC:R-MMU-913531
GO:0034340
GO:0060337

Padj

3.609 × 10–31
1.083 × 10–29
1.036 × 10–15
1.660 × 10–14
2.024 × 10–12
7.840 × 10–12
1.104 × 10–11
5.075 × 10–11
6.886 × 10–11
8.259 × 10–11
6.704 × 10–8

Gene set enrichment analysis of significantly upregulated genes (P < 0.05; FDR < 0.05) from microarray data of
gastric corpus tissue from wild-type mice treated with either HD-Tam for 48 hours (relative to vehicle-treated mice)
or chronically infected with H. pylori identified multiple pathways involved in the sensing and response to dsRNA.
Pathway analysis was performed using g:Profiler (68). FDR, false detection rate; HD-Tam, high-dose tamoxifen.

regions where the gland bases had diffusely progressed to an SPEM pattern (Figure 4I; Supplemental Figure 5,
C and D; and Table 3). In hybrid regions with early SPEM and transitional morphologies (Figure 4H and Supplemental Figure 5, A and B), cells with more cuboidal, mucinous morphology, consistent with SPEM, tended
to have stronger nuclear ADAR1 expression and weaker cytoplasmic ADAR1 expression, with the converse
being the case for cells preserving their chief cell morphology. As chronic atrophic gastritis persists in severity,
intestinal metaplasia can be seen in regions of SPEM (47). Both intestinal metaplasia and SPEM had scant
cytoplasmic and more abundant nuclear ADAR1 expression (Supplemental Figure 5D). Overall, the pattern of
expression was consistent with the pattern of dsRNA accumulation observed in inflamed and metaplastic gastric
epithelium in murine and human stomachs (Figure 1). Taken together, our findings demonstrate that ADAR1 is
activated within mouse and human gastric epithelium undergoing metaplasia and that the dsRNA response can
occur in an epithelium-autonomous manner (i.e., independent of immune and/or mesenchymal cell contribution) if one of the enzymes critical to regulating the response to dsRNA, Adar1, is deleted.
Loss of Adar1 from gastric chief cells activates the dsRNA response in vivo. While loss of Adar1 from gastroids
activated the dsRNA response ex vivo, we wanted to examine the effects of Adar1 deletion on the dsRNA
response specifically within chief cells in vivo (48, 49). We crossed our Adar1-floxed reporter mice (Adar1fl/fl
ROSA26LSLTdTomato) to mice expressing a tamoxifen-inducible Cre under a chief cell–specific promoter (Mist1Cre-ERT/+;
ref. 50). In these mice (Adar1fl/fl Mist1Cre-ERT/+ ROSA26LSLTdTomato), reporter expression was confined to the bases of
gastric corpus glands and colocalized with the murine chief cell-specific marker, GIF (Figure 5, A and B), validating specific Cre-mediated deletion of Adar1 from chief cells. More importantly, loss of Adar1 from chief cells
led to an accumulation of dsRNA within gastric epithelium (Figure 5C, bottom panel). Accordingly, multiple
components of the dsRNA response were induced at the transcriptional (Figure 5D) and protein levels (Figure
5E). It is worth noting that the dsRNA response in these mice peaked within 4 days of completing Cre induction
(see Methods) and subsequently returned to baseline levels by 8 days postinduction (Supplemental Figure 6,
A and B). Thus, specifically deleting Adar1 from gastric chief cells in vivo is sufficient to activate the dsRNA
response, in the absence of exogenous gastric injury (i.e., HD-Tam treatment or chronic H. pylori infection).
Loss of Adar1 does not prevent metaplastic gene expression in chief cells. Given that the dsRNA response, as
well as expression of a crucial regulator of this pathway (i.e., ADAR1), peak in cells undergoing metaplasia, we hypothesized that ADAR1 may be playing a key role in metaplastic reprogramming of these cells.
Previous studies have shown that this reprogramming proceeds by a stepwise, orderly series of intracellular
events, termed paligenosis (25). After initial clearing of cellular components, chief cells undergoing paligenosis first begin to express metaplastic markers (like the epitope for GSII) and subsequently reenter the cell
cycle (26). Given the accumulation of dsRNA within metaplastic chief cells (Figure 1A) and our ability to
conditionally activate the dsRNA response in this cell population (Figure 5), we wanted to determine how
the ADAR1-dependent regulation of the dsRNA response affected paligenosis.
JCI Insight 2022;7(3):e153511 https://doi.org/10.1172/jci.insight.153511
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Figure 3. The dsRNA response during gastric metaplasia is independent of IFNAR1 signaling. (A) RT-PCR of Ifnar1 amplicons from gastric corpus tissue for
wild-type (Ifnar1+/+) and age-matched Ifnar1–/– mice. Each lane represents an individual mouse. Gapdh, loading control. (B) Gastroids from wild-type or Ifnar1–/–
mice were treated with PBS or IFN-β (100 U/mL) for 24 hours and lysates probed with the indicated antibodies. (C) Representative gastric corpus sections of
wild-type or Ifnar1–/– mice treated with vehicle or high-dose tamoxifen (HD-Tam). Right panels highlight representative glands under each treatment. Arrowheads highlight metaplastic glands. Scale bars, 250 μm (left panels), 20 μm (right panels). (D) Metaplastic changes in wild-type and Ifnar1–/– mice infected with
H. pylori (Hp) for 2 weeks. Scale bars, 20 μm. (C and D) Images are representative of 3 mice per experimental treatment. (E) Relative gene expression profiles
between wild-type and Ifnar1–/– mice treated with HD-Tam for 48 hours. Three mice were used per genotype. (F) Fold change expression, relative to vehicle-treated, genotype-matched mice, of various dsRNA transcripts was determined by qRT-PCR. Each data point represents gastric corpus tissue from an individual
mouse across 2 independent experiments. Means (±SEM) are shown. P values were determined using Student’s t test. No significant differences (P > 0.05) were
observed between wild-type and Ifnar1–/– mice for all the transcripts investigated. #, not detected. (G) Gastric corpus tissue from Ifnar1–/– mice following HD-Tam
treatment. Each lane shows a representative mouse from 3 mice per time point. (H) Representative confocal images of Ifnar1–/– gastric corpus gland bases,
following the indicated HD-Tam treatment times, show the accumulation of dsRNA (red). Chief cells are highlighted in green. Images are representative of 3
separate mice per time point. Scale bars, 5 μm.
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Figure 4. ADAR1 is activated within metaplastic gastric epithelium. (A and B) The IFN-inducible (p150) isoform of ADAR1 is upregulated in metaplastic corpus tissue following either HD-Tam treatment (A) or chronic H. pylori infection (B). Each lane of the Western blot shows gastric corpus
tissue from a representative mouse from 3 independent experiments. (C) Isolated ADAR1 (p150) staining (left) and merged images (right) are shown.
A metaplastic gland base from an H. pylori–infected mouse stomach with increased cytoplasmic ADAR1 (p150) expression is shown (bottom right
panel). Scale bars, 20 μm, and 5 μm (bottom right panel). Neck cells are highlighted by GSII staining (green). (D) Adar1 was deleted from murine gastric epithelium by transducing gastroids from Adar1fl/fl mice with an adenoviral Cre vector (Ad-Cre). Fold change expression denotes transcript levels,
relative to Ad-Cre–transduced gastroids derived from Adar1fl/+ mice, from qRT-PCR using a TaqMan array of dsRNA signaling genes. The means (±SD)
from 4–5 independent experiments are shown. Each data point represents gastroid-derived RNA from an individual mouse. Dotted line denotes
2-fold cutoff. (E) Representative Western blot of lysates from Adar1fl/+ or Adar1fl/fl gastroids, either untransduced or transduced with Ad-Cre. (F)
ADAR1 expression in a representative uninflamed gastric corpus biopsy. (G) Representative gastric corpus biopsy from a patient with chronic gastritis
and little to no SPEM. Cytoplasmic ADAR1 staining (brown) can be seen in epithelial cells within inflamed gland bases that have not yet progressed
to SPEM. (H) Representative gastric corpus biopsy from a patient with chronic atrophic gastritis highlighting a hybrid region. Gland bases with early
(*) or more advanced SPEM (***) are shown. (I) Representative gastric corpus biopsy from a patient with diffuse SPEM. Some of the SPEM gland
bases are marked (*). Scale bars, 100 μm (F and I), 50 μm (G and H). GSII, Griffonia simplicifolia lectin.

We assessed the expression of metaplastic and proliferative markers in metaplastic chief cells in our Adar1fl/fl
Mist1Cre-ERT/+ ROSA26LSLTdTomato reporter mice, where we could conditionally and specifically delete Adar1 from
chief cells prior to inducing metaplasia. We triggered Cre-mediated deletion of Adar1 from chief cells prior to
metaplastic injury with HD-Tam (Figure 6A). While it has been shown that lower doses of tamoxifen can
induce an acute damage response (51), we found that the dose of tamoxifen used to activate Cre recombination
in our experimental system (see Methods) did not result in metaplastic changes (Supplemental Figure 6, C and
D; and Figure 6B, Adar1-deficient + Vehicle). In addition, this low dose of tamoxifen did not lead to an accumulation of dsRNA or transcriptional activation of the dsRNA response in wild-type mice (Supplemental Figure 6,
E and F). We observed that metaplastic gene expression was independent of Adar1, as HD-Tam–treated stomachs with Adar1-deficient chief cells (Figure 6B, bottom panel) demonstrated a pattern of metaplastic marker
expression similar to stomachs with Adar1-sufficient chief cells (Figure 6B, top panel) following HD-Tam injury.
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9

RESEARCH ARTICLE

Table 3. Pattern of ADAR1 staining in human gastric biopsy samples
Sample number

Gastritis

PC atrophy

SPEM

IM

ADAR1 staining intensity
(chief cells)

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19

3
4
4
4
1
2
3
4
2
4
2
2
3
2
1
2
3
3
3

1
3
3
3
1
1
2
3
1
3
1
1
2
1
1
1
2
2
3

1
2
4
4
1
1
2
3
1
4
1
1
1
2
1
1
1
1
3

0
1
2
1
0
0
1
1
0
2
0
0
1
0
0
0
2
0
1

3
2
1
1
4
2
3
2
4
2
3
3
2
3
3
2
2
2
2

A total of 19 gastric corpus biopsies of adult patients with chronic gastritis were stained for ADAR1. Biopsies were scored for degree of gastritis, parietal cell
(PC) atrophy, spasmolytic polypeptide-expressing metaplasia (SPEM), and intestinal metaplasia (IM) and for the intensity of cytoplasmic ADAR1 staining
within chief cells. The scoring system for each category is provided in the Methods section. Scoring was performed by a single pathologist who was blinded.

To further corroborate these findings, we used our Adar1fl/fl Mist1Cre-ERT/+ mouse model to conditionally delete Adar1 from chief cells using low-dose tamoxifen, after inducing metaplasia through chronic
H. pylori infection, instead of with HD-Tam (Figure 7A). In the absence of infection, the loss of Adar1
did not cause metaplasia, consistent with experiments in noninjured mice described above (Figure 7B,
Mock + Adar1-deficient). In addition, as after HD-Tam treatment, chronic H. pylori infection caused
chief cells to express metaplastic markers, whether they were Adar1 deficient or sufficient (Figure 7B,
middle and bottom panels). Taken together, our results demonstrate that the induction of metaplastic
markers during chief cell paligenosis does not require Adar1.
Adar1 licenses chief cells to proliferate during paligenosis. During paligenosis, injured chief cells reexpress
metaplastic markers prior to reentering the cell cycle and undergoing proliferation (28). Though Adar1 did
not appear to affect metaplastic gene expression, we wanted to examine whether Adar1 regulated the induction of metaplastic proliferation. We used the same experimental systems for conditionally deleting Adar1
from metaplastic chief cells (Figure 6A and Figure 7A) and assessed cell cycle reentry by staining for Ki-67,
a marker for cells in all stages of the cell cycle. Metaplastic injury, induced with either HD-Tam treatment
(Figure 6C, top panels) or chronic H. pylori infection (Figure 7C, top panels), resulted in the expected
increase in cellular proliferation along the gland axis in both stem/progenitor cells higher in the gland as
well as within Adar1-sufficient, paligenotic chief cells, consistent with previous literature (26, 52). However,
conditional deletion of Adar1 from chief cells dramatically reduced the census of proliferating, paligenotic
chief cells following either HD-Tam–induced (Figure 6C, bottom panels) or H. pylori infection–induced
(Figure 7C, bottom panels) metaplasia. When Adar1 was deleted from chief cells, the basal contribution
to proliferation in the epithelium was specifically abrogated (Figure 6D and Figure 7D). Because H. pylori–induced metaplasia, unlike HD-Tam–induced metaplasia, is multifocal and asynchronous, we chose to
examine the distribution across mice for each treatment. Accordingly, we saw some variation in the pattern
of Ki-67 staining between the 2 H. pylori–infected, Adar1-sufficient mice (Hp + Vehicle, Figure 7D). However, the distribution of Ki-67 staining patterns in multiple quantified regions between the 2 Adar1-deficient
mice was not significantly different, and H. pylori-induced proliferation was significantly suppressed in all
fields of both Adar1-deficient mice (Hp + LD-Tam, Figure 7D). The proliferation defect was confined to
JCI Insight 2022;7(3):e153511 https://doi.org/10.1172/jci.insight.153511
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Figure 5. Deletion of Adar1 from gastric chief cells results in the accumulation of dsRNA and activation of the dsRNA response at homeostasis. (A)
A representative thick section of gastric tissue from an Adar1fl/fl Mist1Cre-ERT/+ ROSA26LSLTdTomato mouse, 4 days after Cre induction, shows Cre recombination (red; endogenous TdTomato signal) occurring specifically within chief cells (green; gastric intrinsic factor, GIF) of the gastric corpus. (B) An
isolated corpus gland base is shown, illustrating Cre recombination (red) in chief cells (green). Scale bars, 100 μm (A) and 5 μm (B). (C) Conditional
deletion of Adar1 from chief cells (bottom) results in the accumulation of dsRNA (red) within gastric epithelium (green). No appreciable dsRNA was
detected in Adar1fl/+ Mist1Cre-ERT/+ gastric epithelium following Cre induction (top). Scale bars, 50 μm. (D) Fold expression changes, as determined by
qRT-PCR, for various transcripts in Adar1fl/fl Mist1Cre-ERT/+ gastric corpus (pink), relative to Adar1fl/+ Mist1Cre-ERT/+ gastric corpus (blue), are shown. Gastric
corpus tissue was collected 4 days after the completion of Cre induction. Each data point represents an individual mouse. The dotted line represents
the average fold change in Adar1fl/+ Mist1Cre-ERT/+ mice. P values were determined by 2-tailed Student’s t test: **, P < 0.01; ***, P < 0.001; ****, P <
0.0001. (E) Representative Western blot demonstrates the activation of various components of the dsRNA response following Cre-mediated deletion
of Adar1. Each lane represents gastric corpus tissue from an individual Adar1fl/fl Mist1Cre-ERT/+ cage mate/littermate mouse at the indicated time point
following the completion of Cre induction. “V” refers to vehicle-treated mice, 4 days after the completion of Cre induction, suggesting that any
potential leaky Cre expression does not result in activation of the dsRNA response.

the basal (paligenotic) cells, as proliferation of progenitor cells higher up in the metaplastic gland axis
was not significantly altered by the loss of Adar1 (Supplemental Figure 7). In addition, pathway analyses
of microarray data confirmed that loss of Adar1 from chief cells prevented the upregulation of multiple
cell cycle pathways in response to HD-Tam (Figure 6E). These results therefore demonstrate that Adar1 is
required for chief cells to appropriately engage the proliferative stage during paligenosis.
Adar1 deficiency promotes apoptosis following metaplastic injury. Previous reports have indicated that ADAR1
regulates epithelial cell survival at homeostasis (53, 54). Though deletion of Adar1 from chief cells triggered
dsRNA signaling (Figure 5, D and E), it did not cause chief cell loss at homeostasis (Supplemental Figure 6D).
JCI Insight 2022;7(3):e153511 https://doi.org/10.1172/jci.insight.153511
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Figure 6. Loss of Adar1 from chief cells does not affect metaplastic gene expression but limits cellular proliferation following HD-Tam treatment.
(A) Adar1fl/fl Mist1Cre-ERT/+ ROSA26LSLTdTomato mice were treated with either vehicle or low-dose tamoxifen (LD-Tam) for 7 days to induce Cre-mediated
deletion of Adar1 from chief cells. Four days later, mice were treated with either vehicle or high-dose tamoxifen (HD-Tam) for an additional 2 days to
induce metaplasia, then euthanized 1 day after the last injection. (B) Metaplastic changes in mice with Adar1-sufficient (middle) and -deficient (bottom) chief cells after HD-Tam injury. Arrowheads point to metaplastic glands. Chief cells are labeled with GIF (red), neck cells with GSII (green). Scale
bars, 50 μm (left panels), 10 μm (right panels). (C) Adar1-deficient chief cells show decreased Ki-67 staining following HD-Tam treatment (bottom),
compared with HD-Tam–treated, Adar1-sufficient chief cells (top). The gland base and neck regions are indicated by brackets. For B and C, representative gland bases are shown in right panels, with TdTomato signal demonstrating Mist1Cre-ERT lineage tracing in chief cells. For B and C, images are
representative of 3–4 mice per experimental condition. (D) The number of Ki-67–positive cells per gland base was quantified for each experimental
setup. Each data point represents the mean number of Ki-67–positive cells per gland across randomly selected fields from an individual mouse, and
the mean (±SD) of those data points is indicated. P values were determined by 1-way ANOVA using Tukey’s multiple comparisons test. (E) Gene set
enrichment analysis demonstrates molecular pathways enriched in gastric corpus tissue from Adar1-sufficient (black) and -deficient (gray) chief cells
after 48 hours of HD-Tam injury. Adjusted P values were determined using g:Profiler (68). Microarray data were obtained from 3 individual mice per
experimental condition. GIF, gastric intrinsic factor; GSII, Griffonia simplicifolia lectin.
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Figure 7. Loss of chief cell–specific Adar1 does not affect metaplastic gene expression but limits proliferation during chronic H. pylori infection. (A) Adar1fl/fl
Mist1Cre-ERT/+ mice were either mock-infected or infected with H. pylori (Hp) for 10 months to induce metaplasia, followed by 7 days of either vehicle or lowdose tamoxifen (LD-Tam) treatment to induce Cre-mediated deletion of Adar1 from chief cells. Mice were euthanized 4 days later. (B) During chronic H. pylori
infection, Adar1-deficient chief cells (bottom) acquire metaplastic changes similar to chronically infected Adar1-sufficient chief cells (middle). Representative
metaplastic gland bases (right panels) are shown. Scale bars, 50 μm (left panels), 10 μm (right panels). (C) Adar1-deficient chief cells show decreased Ki-67
staining following H. pylori infection (bottom), compared with chronically infected Adar1-sufficient chief cells (top). Representative gland bases (right panels)
are shown. Scale bars, 50 μm (left panels), 5 μm (right panels). For B and C, images are representative of 2 mice per experimental treatment. (D) The distributions of Ki-67–positive cells at the gland base following H. pylori infection of mice with Adar1-sufficient (blue) or -deficient (red) chief cells are shown. Each data
point represents a randomly selected field. No significant difference was seen between the distributions of H. pylori–infected mice with Adar1-deficient chief
cells, but all H. pylori–infected mice with Adar1-deficient chief cells had significantly fewer Ki-67–positive cells at the gland base compared with H. pylori–infected mice with Adar1-sufficient chief cells. Few, if any, Ki-67–positive chief cells could be appreciated in mock-infected mice with Adar1-deficient chief cells, and
this number was not determined. P values were calculated by 1-way ANOVA using Tukey’s multiple comparisons test. A statistically significant difference (P =
0.0022) was also found between H. pylori-infected, Adar1-sufficient and -deficient mice by Mann-Whitney test.
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However, we reasoned that the inability of Adar1-deficient chief cells to proliferate during paligenosis could be
because accumulation of and/or response to dsRNA during paligenosis is critical for cell survival in a manner
not observed during homeostasis. Accordingly, while Adar1-deficient chief cells in the absence of metaplastic
injury did not undergo any appreciable cell death (Figure 8A, Adar1-deficient + vehicle), metaplastic glands
containing Adar1-deficient chief cells (Figure 8, C–E) showed a higher proportion of TUNEL-positive cells at
their bases compared with metaplastic glands with Adar1-sufficient chief cells (Figure 8B). It is worth noting
that we quantified TUNEL-positive cells only within gland bases, as luminal pit cells undergo apoptosis at
homeostasis as part of normal cell turnover (55). Indeed, TUNEL positivity within the pit region served as
an internal staining control for our assay (Figure 8A). These results suggest that Adar1 regulates chief cell
survival during paligenosis (but not during homeostasis) and that the loss of Adar1 from metaplastic chief
cells promotes cell death.

Discussion
Our findings reveal a potentially novel, cell-intrinsic role for ADAR1 and dsRNA signaling in gastric metaplasia, a critical preneoplastic stage in the progression to gastric cancer (56). While dsRNA signaling has
been indirectly linked to gastric tumorigenesis (57), our study offers new insight into the importance of
ADAR1 during cellular stress and how it dictates epithelial cell fate during injury. It seems likely, though
it has not been explicitly shown, that the accumulation of dsRNA may somehow be a normal aspect of
development and differentiation. Adar1-deficient mice are not viable (18, 58), show increased levels of ISGs
that reinforce the IFN response (17), and are rescued to attain adulthood only if they concurrently lack an
ability to sense cytosolic dsRNA (18). If one considers that the cellular reprogramming of a postmitotic,
differentiated cell during metaplasia (i.e., paligenosis) represents a reversion to a more fetal like state (59),
then it would stand to reason that sensing of dsRNA and ADAR1-mediated downstream signaling are
inherent to this process.
Though ADAR1 has a prosurvival role in other gastrointestinal tissues at homeostasis (53, 54), our
results suggest that gastric epithelial ADAR1 is relevant only during cellular stress. The prosurvival, or rather antideath, function of ADAR1 could occur through several recently proposed mechanisms, all within
the context of cellular stress. One of the earliest functional characterizations of ADAR1 suggested its role
in regulating survival of murine embryonic fibroblasts during serum starvation (58). A more recent study
mechanistically detailed the role of ADAR1 in regulating apoptosis in A172 cells, where the phosphorylated p110 isoform inhibited Staufen 1–mediated decay of antiapoptotic mRNAs (60). In human neural progenitor cells, ADAR1 prevents endogenous RNA from triggering translational shutdown by impeding the
phosphorylation and activation of PKR (44). Our results are consistent with these phenotypes and expand
ADAR1’s role specifically within a metaplastic cell population in vivo.
The step of paligenosis that decides whether metaplastic cells reenter the cell cycle is critical, as it is
carefully licensed to prevent cells carrying DNA damage from proliferating (28). It has been suggested that
ADAR1 functions as an oncogene in various cancer cell lines (61) and even in a xenograft model of gastric
cancer (32). Our findings suggest that ADAR1 may be critical for oncogenesis because it regulates this key
reentry of metaplastic cells into the cell cycle. Indeed, the proliferation of metaplastic epithelium serves a
reparative, wound-healing function, but in the setting of sustained injury, every reentry into the cell cycle
has the potential to enable the accumulation of mutations that can eventually be unmasked when expressed
in proliferating cells (62, 63). In addition to playing a role in allowing progression to the proliferative state,
ADAR1 might also play a role in minimizing the mutational burden during metaplasia, through its role as
an RNA-editing enzyme (33). In any case, ADAR1 clearly plays a unique role in regulating cell decisions
during a crucial precancerous state in the stomach.
dsRNA signaling in vertebrates has become synonymous with the generation of an antiviral state, and
it has been assumed that this pathway evolved as a method for cells to sense and defend against viral infection (2). One should consider, however, that the dsRNA response (along with the sensing of other nucleic
acids) and the production of type I IFNs may represent an even more evolutionarily conserved method
(64) to sense intracellular dsRNA (or other nucleic acids) during the cellular stress that accompanies organ
development and/or epithelial injury. Future studies will help identify conserved dsRNA signaling mechanisms that underlie development, metaplasia, and regeneration across other cell types and investigate how
therapeutic manipulation of this pathway affects the progression to cancer in an organ-specific context.
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Figure 8. Loss of Adar1 from chief cells results in more cell death during gastric metaplasia. (A–C) The loss of
Adar1 from chief cells leads to a greater frequency of dying cells (green) following HD-Tam–induced metaplasia (C),
compared with HD-Tam–treated stomachs with Adar1-sufficient chief cells (B). The experimental setup is as shown
in Figure 6A. Without HD-Tam injury, chief cell Adar1 deficiency does not induce cell death at gland bases (A). For
A–C, isolated TUNEL signals are shown in the top panels, with merged images in the bottom panels. (D) Adar1-deficient chief cell (red) undergoing death following metaplastic injury. Scale bars, 50 μm (A–C), 5 μm (D). (E) Each data
point represents the mean (±SEM) TUNEL-positive cells per gland base from multiple randomly selected fields from
an individual mouse. Three to 4 independent experiments are shown. P values were determined by 1-way ANOVA
using Tukey’s multiple comparisons test.

Methods
Mice. Mice were maintained in a specified germ-free barrier facility under a 12-hour light cycle. All experiments involving germ-free mice were performed at the Gnotobiotic Core Facility at the Washington University in St. Louis School of Medicine. All mice used for experiments were 6–8 weeks of age. Mice had
access to food and water ad libitum. Wild-type C57BL/6, ROSA26LSLTdTomato, and Ifnar1–/– male and female
mice were obtained from the Jackson Laboratory. The generation and validation of Adar1-floxed mice
(provided by Qingde Wang, University of Pittsburgh Medical Center, Pittsburgh, PA, USA) have been
previously described (58), and all other mice used were generated in-house.
Antibodies. Information regarding all antibodies used in this study, including the manufacturer and
catalog numbers, is provided in Table 4.
Tamoxifen experiments. For HD-Tam experiments, mice were intraperitoneally injected with 2 consecutive daily doses of a tamoxifen/ethanol/sunflower seed oil mixture at a dose of 5 mg/20 g body
weight, as previously described (34). For experiments involving Cre recombinase induction (LD-Tam),
mice were intraperitoneally injected daily with a tamoxifen/ethanol/sunflower seed oil mixture at a dose
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Table 4. Antibodies used in this study
Antibody

Supplier

Catalog number

Rabbit anti-DDX58
Rabbit anti-STAT1
Rabbit anti–phospho-STAT1
Rabbit anti-IRF9
Mouse anti–β-actin
Rabbit anti-ADAR1 (p150)
Rabbit anti-ADAR1
Mouse anti-dsRNA (K1)
Rabbit anti-GIF

Cell Signaling Technology
Cell Signaling Technology
Cell Signaling Technology
Cell Signaling Technology
MilliporeSigma
Synaptic Systems
Atlas Antibodies
Scicons
David Alpers (Washington University in
St. Louis School of Medicine, St. Louis, Missouri, USA)
Cell Signaling Technology
Invitrogen
Thermo Fisher Scientific
Invitrogen
Abcam
Thermo Fisher Scientific

3743
9172
9167
28845
A2228
293003
HPA003890
10020200
N/A

Rabbit anti–E-cadherin (24E10)
GSII lectin
Rabbit anti-IRF7
Alexa Fluor 647 Phalloidin
Rabbit anti–Ki-67
Hoechst 33258

3195
L21415
PA5-20280
A22287
ab15580
H3569

of 1 mg/20 g body weight for 7 consecutive days. This protocol has been shown to induce Cre recombinase without causing metaplasia (51).
H. pylori infection. Growth of the wild-type PMSS1 strain of H. pylori (provided by Rick Peek, Vanderbilt University, Nashville, Tennessee, USA) has been previously described (65). Briefly, mice were orally
gavaged with 200 μL of either Brucella broth (Thermo Fisher Scientific) (mock infection) or PMSS1 diluted
in Brucella broth (~1 × 108 CFU/mouse) for the indicated times.
Microarray analyses. Gastric corpus tissue from wild-type C57BL/6 littermate/cage mate mice was
directly placed in RLT buffer containing 2-mercaptoethanol, and RNA was isolated using the RNeasy
Mini Kit (QIAGEN), per the manufacturer’s instructions. Gene expression profiling was performed using
microarray analysis in collaboration with the Genome Technology Access Core at the Washington University in St. Louis School of Medicine. RNA was amplified using the WT Plus kit (Thermo Fisher Scientific)
and hybridized to Agilent 8 × 60 gene chips. All data were analyzed using the Transcriptome Analysis
Console software (Thermo Fisher Scientific). Microarray data were uploaded to the National Center for
Biotechnology Information’s Gene Expression Omnibus database with the following accession numbers:
GSE190508, GSE190509, and GSE190563.
Mouse gastroid culture. The growth and passaging of mouse gastroids was adapted from previously established protocols (66, 67). Mouse gastric corpus glands were isolated by gently stripping away
gastric corpus mucosa into gland isolation buffer (5.6 mM Na2HPO4, 8 mM KH2PO4, 96 mM NaCl,
1.6 mM KCl, 44 mM sucrose, 55 mM d-sorbitol, 0.5 mM DTT) using fine forceps. The mucosa was
incubated in chelation buffer (gland isolation buffer, 10 mM EDTA) for 2 hours at 4°C, then washed
7 times with cold wash buffer (gland isolation buffer without DTT, 1% fetal bovine serum) to isolate
gastric glands. Supernatants were pooled and pelleted at 150g at 4°C for 5 minutes. The gland pellet was
resuspended in Matrigel (Corning), and 50 μL was plated into each well of a 24-well plate supplemented with 500 μL of conditioned medium (Advanced DMEM/F12 from Gibco, HEPES from Corning,
GlutaMAX from Gibco, N2 supplement, B27 supplement, 1 mM N-acetylcysteine, 50 ng/mL EGF,
200 ng/mL FGF10, 10 nM gastrin, 10 μM Y-27632, primocin, 50% Wnt3a-conditioned medium, 10%
R-spondin/noggin–conditioned medium) and incubated at 37°C and 5% CO2. Gastroids were passaged
as previously described (66). All gastroid-related experiments used gastroids after the first passage.
Adenoviral transduction of mouse gastroids. Mouse gastroids were grown as described. Conditioned medium
was removed, and gastroids were washed 3 times with cold PBS on ice. Gastroids were resuspended in cold
PBS by gently disrupting the Matrigel with pipetting, then pelleted at 150g for 5 minutes at 4°C. The pellet was
resuspended in TrypLE Express (Gibco) for 5 minutes at 37°C and 5% CO2, and trypsinization was quenched
with quenching buffer (Advanced DMEM/F12, 10% fetal bovine serum). Cells were pelleted at 150g for 5 minutes at 4°C and resuspended in warm conditioned medium. The Ad-Cre vector (Vector Biolabs) was diluted in
JCI Insight 2022;7(3):e153511 https://doi.org/10.1172/jci.insight.153511

16

RESEARCH ARTICLE

conditioned medium and added to the cell suspension at a multiplicity of infection of 100. This mixture was
gently shaken at 30 rpm at 37°C and 5% CO2 for 30 minutes, then pelleted at 2152g and 37°C for 5 minutes.
The pellet was resuspended in Matrigel on ice, plated onto a 24-well plate, and incubated in conditioned medium at 37°C and 5% CO2. Gastroids were processed 4–6 days after transduction.
Processing of mouse gastroids. For RNA isolation, gastroids were washed 3 times with cold PBS, then
resuspended in cold PBS and pelleted at 2152g for 5 minutes at 4°C. RLT buffer containing 2-mercaptoethanol was directly added to the gastroid pellet, and RNA was isolated using the RNeasy Mini Kit, per
the manufacturer’s instructions. For protein isolation, gastroids were washed and pelleted, and the pellet
was sonicated 3 times in RIPA buffer (Pierce) containing a protease inhibitor cocktail (Thermo Fisher
Scientific) on ice. Samples were centrifuged at 21,130g for 30 minutes at 4°C, and the supernatants were
collected. Protein concentrations in the supernatants were determined using the BCA Protein Assay kit
(Thermo Fisher Scientific). For immunofluorescence staining of gastroids, gastroids were washed and
pelleted, then fixed in 4% paraformaldehyde (PFA) for 15 minutes at 37°C. Gastroids were washed with
PBS, then blocked in blocking buffer (PBS, 3% bovine serum albumin, 1% saponin, 1% Triton X-100)
for 2 hours at room temperature. Gastroids were then stained with Alexa Fluor-conjugated phalloidin
diluted in blocking buffer (1:100) overnight at 4°C. The next day, gastroids were washed with PBS and
incubated in PBS with Hoechst 33258 (1:20,000) for 30 minutes at room temperature. Gastroids were
washed and mounted with ProLong Gold antifade reagent (Thermo Fisher Scientific) prior to confocal
imaging. The Cytation3 imaging multimode reader (BioTek) was used to obtain bright-field and fluorescent images of gastroids, and the Gen5 Data Analysis software (BioTek) was used for image analysis.
qRT-PCR. RNA was extracted using the RNeasy Mini Kit, per the manufacturer’s instructions. RNA
was converted to cDNA using the PrimeScript cDNA synthesis kit (Takara). qRT-PCR was performed
using SYBR Green on the QuantStudio 3 instrument (Applied Biosystems). For qRT-PCR analysis of
mouse gastroid RNA, cDNA was added to a custom TaqMan Array 96-well Fast plate (Applied Biosystems) using TaqMan Fast Advanced Master Mix and TaqMan Gene Expression Master Mix, per the
manufacturer’s instructions.
Western blotting. Mouse gastric corpus tissue was snap-frozen in liquid nitrogen and stored at –80°C
until further use. Tissue was thawed in RIPA buffer containing protease inhibitor cocktail on ice, then
sonicated 3 times on ice. Lysates were centrifuged at 21,130g for 30 minutes at 4°C, and the protein concentrations from the supernatants were determined using the BCA Protein Assay Kit (Pierce). Lysates
were diluted in NuPAGE (Thermo Fisher Scientific) loading buffer and NuPAGE sample reducing
agent, then loaded onto NuPAGE 12% Bis-Tris gels. Gels were transferred to 0.45 μm nitrocellulose
membranes (MilliporeSigma). Membranes were blocked in Tris-buffered saline with 0.1% Tween-20
containing 5% nonfat milk prior to probing with the appropriate antibodies. Blots were developed using
SuperSignal West Pico chemiluminescent substrate (Thermo Fisher Scientific). Information related to
the antibodies used for Western blotting, including supplier and catalog numbers, is provided in Table 4.
See complete unedited blots in the supplemental material.
Immunofluorescence. Mouse stomachs were excised, cut open along the lesser curvature, pinned down in 4%
PFA, and fixed overnight at 4°C. The next day, longitudinal stomach strips were embedded in 4% low-melting
agarose, and 100 μm sections were cut using a vibratome (Leica Biosystems). Sections were blocked for 2
hours in blocking buffer, then incubated overnight at 4°C in the appropriate primary antibody. The following
antibodies were used for immunofluorescence: K1 mouse anti-dsRNA (1:70), rabbit anti–E-cadherin (1:100),
GSII (1:1000), rabbit anti-GIF (1:10,000), rabbit anti-IRF7 (1:100), phalloidin (1:100), rabbit anti-ADAR1
(p150 isoform; 1:100; Synaptic Systems), rabbit anti–Ki-67 (1:100), and TUNEL staining kit (MilliporeSigma). Additional information related to the antibodies used for immunofluorescence, including supplier and
catalog numbers, is provided in Table 4. Sections were washed and incubated in the appropriate secondary
antibodies for 2 hours at room temperature. Sections were then incubated in Hoechst 33258 stain (1:20,000)
for 30 minutes at room temperature, transferred to a microscope slide, and mounted using ProLong Gold
antifade reagent. Images were obtained using the Olympus FV1200 confocal microscope, and Z-stacks were
reconstructed into 3-dimensional images using Amaris software (Thermo Fisher Scientific).
Immunohistochemistry. Paraffin-embedded (5 μm) sections of human gastric specimens were deparaffinized and rehydrated according to routine paraffin processing protocols. Endogenous peroxidase activity was quenched with 1.5% H2O2 in methanol for 15 minutes at room temperature. Slides were boiled for
10 minutes in 10 mM sodium citrate (pH 6.0), then blocked for 2 hours at room temperature in blocking
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buffer (see Immunofluorescence) in a humidity chamber. Slides were subsequently blocked using the Avidin/Biotin blocking kit (Vector Laboratories), according to the manufacturer’s protocol. For ADAR1
staining, slides were incubated in rabbit anti-ADAR1 (p110 and p150 isoforms; 1:100; Atlas) overnight
at 4°C and washed with PBS the next day. For all quantification of Ki-67 staining, paraffin-embedded,
murine gastric corpus tissue was processed as above. Tissue was incubated overnight at 4°C in rabbit
anti–Ki-67 antibody (1:100; Abcam), then washed the next day in PBS prior to incubating in the corresponding secondary antibodies. For both ADAR1 and Ki-67 staining, signal was amplified using the
VectaStain Elite ABC kit (Vector Laboratories) and developed using 3,3′-diaminobenzidine tetrahydrochloride (Thermo Fisher Scientific). Slides were counterstained with eosin or hematoxylin according to
routine staining protocols. For all quantification of Ki-67 staining, gastric corpus sections were scored by
an observer blinded to the genotype and treatment. The number of Ki-67–positive cells per gland base,
where chief cells and metaplastic chief cells reside and which was uniformly determined by the blinded
observer for each quantified strip, was determined.
Histologic scoring. For Table 3, gastric corpus biopsies were stained with the ADAR1 antibody and counterstained with hematoxylin. Biopsies were evaluated by a blinded pathologist and scored 1–4, with 4 being
most severe for gastritis (i.e., degree of chronic inflammatory infiltrate), PC atrophy (degree of PC loss),
SPEM (extent of basal replacement of chief cells by mucous cells), and intensity/extent of cytoplasmic
ADAR1 staining in chief cells. IM was evaluated from 0 to 2, with 0 referring to no IM detected, 1 meaning
focal IM, and 2 meaning extensive IM.
Statistics. For qRT-PCR, mRNA expression was determined using the ΔΔCt method with normalization to the housekeeping gene Gapdh. All statistical tests and numbers of biological replicates can be
found in the figure legends. Where applicable, results are presented as means ± standard deviation (SD)
or standard error of the mean (SEM). All quantification was done by an observer who was blinded to
the experimental treatments. Comparisons between treatments were made using either 2-tailed Student’s t
test, Mann-Whitney test, or 1-way ANOVA using Tukey’s multiple comparisons test, where appropriate.
P values are provided where appropriate and considered significant for P < 0.05. Statistical analyses were
performed using GraphPad Prism 9.0. Gene set enrichment analyses, including calculation of adjusted P
values, was performed using g:Profiler software (68).
Study approval. All human gastric specimens were obtained through a collaboration between JBS and
the Universidad del Cauca (Popayán, Colombia), with approval from the Institutional Review Boards
at the Universidad del Cauca and at the Washington University in St. Louis School of Medicine (IRB
201901176). Informed written consent was obtained for use of these samples as approved by the appropriate Institutional Review Board. All experiments involving mice were performed according to protocols
approved by the Washington University in St. Louis School of Medicine Animal Studies Committee.
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